Terms: = Leukemia AND FOXO3, FKHRL1, 2309, ENSG00000118689, MGC31925, MGC12739, FOXO2, FOXO3A, O43524, AF6q21, FKHRL1P2, DKFZp781A0677 AND Treatment
63 results:
1. Expression of genes potentially involved in loss of response in patients with chronic myeloid leukemia.
Benegas P; Ziegler B; Dieminger V; Bengió R; Zapata P; Larripa I; Ferri C
Gene; 2024 Feb; 896():148047. PubMed ID: 38042214
[TBL] [Abstract] [Full Text] [Related]
2. The discrete roles of individual FOXO transcription factor family members in B-cell malignancies.
Lees J; Hay J; Moles MW; Michie AM
Front Immunol; 2023; 14():1179101. PubMed ID: 37275916
[TBL] [Abstract] [Full Text] [Related]
3. Transglutaminase 2 associated with PI3K and PTEN in a membrane-bound signalosome platform blunts cell death.
Jambrovics K; Botó P; Pap A; Sarang Z; Kolostyák Z; Czimmerer Z; Szatmari I; Fésüs L; Uray IP; Balajthy Z
Cell Death Dis; 2023 Mar; 14(3):217. PubMed ID: 36977701
[TBL] [Abstract] [Full Text] [Related]
4. Prognostic value and therapeutic targeting of XPO1 in chronic lymphocytic leukemia.
Xu Z; Pan B; Miao Y; Li Y; Qin S; Liang J; Kong Y; Zhang X; Tang J; Xia Y; Zhu H; Wang L; Li J; Wu J; Xu W
Clin Exp Med; 2023 Oct; 23(6):2651-2662. PubMed ID: 36738306
[TBL] [Abstract] [Full Text] [Related]
5. A FOXO1-dependent transcription network is a targetable vulnerability of mantle cell lymphomas.
Jang JY; Hwang I; Pan H; Yao J; Alinari L; Imada E; Zanettini C; Kluk MJ; Wang Y; Lee Y; Lin HV; Huang X; Di Liberto M; Chen Z; Ballman KV; Cantley LC; Marchionni L; Inghirami G; Elemento O; Baiocchi RA; Chen-Kiang S; Belvedere S; Zheng H; Paik J
J Clin Invest; 2022 Dec; 132(24):. PubMed ID: 36282572
[TBL] [Abstract] [Full Text] [Related]
6. Phosphoproteomics of primary AML patient samples reveals rationale for AKT combination therapy and p53 context to overcome selinexor resistance.
Emdal KB; Palacio-Escat N; Wigerup C; Eguchi A; Nilsson H; Bekker-Jensen DB; Rönnstrand L; Kazi JU; Puissant A; Itzykson R; Saez-Rodriguez J; Masson K; Blume-Jensen P; Olsen JV
Cell Rep; 2022 Aug; 40(6):111177. PubMed ID: 35947955
[TBL] [Abstract] [Full Text] [Related]
7. The glycolytic enzyme PFKFB3 determines bone marrow endothelial progenitor cell damage after chemotherapy and irradiation.
Lyu ZS; Tang SQ; Xing T; Zhou Y; Lv M; Fu HX; Wang Y; Xu LP; Zhang XH; Lee HY; Kong Y; Huang XJ
Haematologica; 2022 Oct; 107(10):2365-2380. PubMed ID: 35354250
[TBL] [Abstract] [Full Text] [Related]
8. Combination therapy using TGF-β1 and STI-571 can induce apoptosis in BCR-ABL oncogene-expressing cells.
Bakhshayesh M; Gohari LH; Barati M; Safa M
Biomol Concepts; 2021 Oct; 12(1):144-155. PubMed ID: 34700368
[TBL] [Abstract] [Full Text] [Related]
9. Synergistic effects of BKM120 and panobinostat on pre-B acute lymphoblastic cells: an emerging perspective for the simultaneous inhibition of PI3K and HDACs.
Mehrpouri M; Momeny M; Bashash D
J Recept Signal Transduct Res; 2022 Feb; 42(1):100-108. PubMed ID: 33969806
[TBL] [Abstract] [Full Text] [Related]
10. DP from Euphorbia fischeriana S. mediated apoptosis in leukemia cells via the PI3k/Akt signaling pathways.
Ma L; Chen Z; Li J; Zhang H; Jia Y; Liu J
J Ethnopharmacol; 2021 Oct; 279():113889. PubMed ID: 33524514
[TBL] [Abstract] [Full Text] [Related]
11. Downregulation of PUMA underlies resistance to FGFR1 inhibitors in the stem cell leukemia/lymphoma syndrome.
Liu Y; Cai B; Chong Y; Zhang H; Kemp CA; Lu S; Chang CS; Ren M; Cowell JK; Hu T
Cell Death Dis; 2020 Oct; 11(10):884. PubMed ID: 33082322
[TBL] [Abstract] [Full Text] [Related]
12. FLT3 inhibition upregulates HDAC8 via FOXO to inactivate p53 and promote maintenance of FLT3-ITD+ acute myeloid leukemia.
Long J; Jia MY; Fang WY; Chen XJ; Mu LL; Wang ZY; Shen Y; Xiang RF; Wang LN; Wang L; Jiang CH; Jiang JL; Zhang WJ; Sun YD; Chang L; Gao WH; Wang Y; Li JM; Hong DL; Liang AB; Hu J
Blood; 2020 Apr; 135(17):1472-1483. PubMed ID: 32315388
[TBL] [Abstract] [Full Text] [Related]
13. ZnO/CNT@Fe
Yousefi AM; Safaroghli-Azar A; Fakhroueian Z; Bashash D
Artif Cells Nanomed Biotechnol; 2020 Dec; 48(1):735-745. PubMed ID: 32272856
[TBL] [Abstract] [Full Text] [Related]
14. An Overview of the Potential Antineoplastic Effects of Casticin.
Ramchandani S; Naz I; Lee JH; Khan MR; Ahn KS
Molecules; 2020 Mar; 25(6):. PubMed ID: 32178324
[TBL] [Abstract] [Full Text] [Related]
15. Co-inhibition of BET proteins and PI3Kα triggers mitochondrial apoptosis in rhabdomyosarcoma cells.
Boedicker C; Hussong M; Grimm C; Dolgikh N; Meister MT; Enßle JC; Wanior M; Knapp S; Schweiger MR; Fulda S
Oncogene; 2020 May; 39(19):3837-3852. PubMed ID: 32161312
[TBL] [Abstract] [Full Text] [Related]
16. Arsenic trioxide inhibits angiogenesis in vitro and in vivo by upregulating foxo3a.
Sun Z; Li M; Bai L; Fu J; Lu J; Wu M; Zhou C; Zhang Y; Wu Y
Toxicol Lett; 2019 Oct; 315():1-8. PubMed ID: 31421153
[TBL] [Abstract] [Full Text] [Related]
17. PLZF regulates apoptosis of leukemia cells by regulating AKT/foxo3a pathway.
Li JX; Zhang ZF; Wang XB; Yang EQ; Dong L; Meng J
Eur Rev Med Pharmacol Sci; 2019 Aug; 23(15):6411-6418. PubMed ID: 31378879
[TBL] [Abstract] [Full Text] [Related]
18. miR-183-5p Inhibits Occurrence and Progression of Acute Myeloid leukemia via Targeting Erbin.
Zheng Z; Zheng X; Zhu Y; Gu X; Gu W; Xie X; Hu W; Jiang J
Mol Ther; 2019 Mar; 27(3):542-558. PubMed ID: 30799283
[TBL] [Abstract] [Full Text] [Related]
19. Akt2 mediates glucocorticoid resistance in lymphoid malignancies through foxo3a/Bim axis and serves as a direct target for resistance reversal.
Xie M; Yang A; Ma J; Wu M; Xu H; Wu K; Jin Y; Xie Y
Cell Death Dis; 2019 Jan; 9(10):1013. PubMed ID: 30598523
[TBL] [Abstract] [Full Text] [Related]
20. Overexpression of Hes1 is involved in sensitization of K562 cells to Imatinib.
Eskandari S; Yazdanparast R
J Cell Biochem; 2019 Jun; 120(6):10128-10136. PubMed ID: 30548309
[TBL] [Abstract] [Full Text] [Related]
[Next]
